Amicus Therapeutics Earning Date (FOLD)

USA |NASDAQ |USD

FOLD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 7, 2022 Sep 2022 $-0.19 - $-0.19
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 7, 2022 Sep 2022 $91.33M - $79.55M

Amicus Therapeutics's next earnings date is Monday, Nov 7, 2022 for the fiscal quarter ending Sep 2022.

FOLD Earnings Date & History Chart

FOLD Earnings & Revenue Forecast

FOLD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 10 $-0.19 $-0.24 $-0.13
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 11 $-0.88 $-1.01 $-0.67
Dec 2023 11 $-0.15 $-0.37 $0.05

FOLD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 5 / 0 $-0.18 $-0.18 $-0.18
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-0.80 $-0.79 $-0.79
Dec 2023 4 / 0 $-0.13 $-0.12 $-0.07

FOLD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Sep 2022 11 $91.33M $86.00M $94.80M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 12 $357.19M $336.93M $367.75M
Dec 2023 12 $491.43M $441.06M $565.00M

FOLD Earnings Date & Revenue History

FOLD Earnings History

|
Show More
Show More

FOLD Revenue History

|
Show More
Show More

Amicus Therapeutics Next Earnings Date & Report

FOLD Next Earnings Date & Report Preview: Sep 2022 (FQ)

FOLD's next earnings date is Monday, Nov 7, 2022 for the fiscal quarter ending Sep 30, 2022.

According to analysts, the average EPS estimation for Amicus Therapeutics's next quarterly earnings is $-0.19, with a low EPS estimation of $-0.24, and a high estimation of $-0.13.

Over the last 1 month, EPS estimates have seen 5 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.18, and the 3 month trend is $-0.18.

Based on analysts, the average revenue estimation is $91.33M, with a low revenue estimation of $86.00M, and a high estimation of $94.80M.

Amicus Therapeutics Previous Earnings Dates & Reports

FOLD Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Amicus Therapeutics's previous earnings date was Aug 3, 2022 for its fiscal quarter ended Jun 30, 2022.

FOLD Previous Earnings Date & Report Recap: Dec 2021 (FY)

Amicus Therapeutics's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.

FOLD's earnings per share (EPS) was $-0.92, missing the consensus analysts forecast of $-0.78 by 17.95% , and higher than the previous year's EPS (Dec 2020) by -14.02%.

Revenues were $305.51M, worse than the forecast of $307.10M by -0.52%, and up by 17.11% from previous year's revenue.

The company reported a net income of $-250.46M.

Amicus Therapeutics reported a free cash flow of $-206.38M for its fiscal year, compared to $-236.52M a year ago.

The company ended the fiscal year with $440.13M in total debt, an increase of 11.11% compared to the previous year.